Inflammatory dietary pattern and incident psoriasis, psoriatic arthritis, and atopic dermatitis in women: A cohort study - 16/05/19
Abstract |
Background |
Diet is a modulator of inflammation that might impact inflammatory skin diseases.
Objective |
To assess the relationship between pro-inflammatory dietary patterns and incident psoriasis, psoriatic arthritis (PsA), and atopic dermatitis (AD).
Methods |
We conducted cohort studies among women in the Nurses' Health Study II. The Empirical Dietary Inflammatory Pattern (EDIP) score was calculated at baseline and every 4 years. Incident psoriasis, PsA, and AD were assessed by validated self-report. We used multivariable-adjusted Cox proportional hazards models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between EDIP quintiles and risk for psoriasis, PsA, and AD.
Results |
We had 85,185 participants in the psoriasis analysis and 63,443 in the AD analysis. There were 1432 cases of psoriasis, 262 cases of PsA, and 403 cases of AD. Pro-inflammatory dietary patterns were not associated with the risk for outcomes in multivariable models (all P values for trend >.05). HRs comparing the highest to the lowest EDIP quintile were 0.99 (95% CI 0.83-1.18) for psoriasis, 1.22 (95% CI 0.81-1.83) for PsA, and 0.96 (95% CI 0.69-1.34) for AD.
Limitations |
Recall and self-report.
Conclusion |
Our findings do not support dietary inflammatory potential as a risk factor for psoriasis, PsA, or AD.
Le texte complet de cet article est disponible en PDF.Key words : atopic dermatitis, CRP, EDIP, IL-6, inflammatory diet, Nurses' Health Study II, psoriasis, psoriatic arthritis, TNF-α
Abbreviations used : BMI, CI, CRP, EDIP, HR, IL-6, NHS-II, TH1, TNF-α
Plan
| Funding sources: Supported by the Brown University Department of Dermatology and an investigator-initiated grant from Regeneron and Sanofi (to Dr Qureshi) from the National Institutes of Health (CA207736 and CA176726) and R00CA207736 from the National Cancer Institute. |
|
| Conflicts of interest: In the past 3 years, Dr Drucker served as an investigator and has received research funding from Sanofi and Regeneron and has been a consultant for Sanofi, RTI Health Solutions, Eczema Society of Canada, and the Canadian Agency for Drugs and Technology in Health. He has received honoraria from Prime Inc, Spire Learning, CME Outfitters, and Eczema Society of Canada. His institution receives education grants from Sanofi. Dr Qureshi has served as a consultant (honoraria donated to charity) for Eli Lilly, Amgen, Centers for Disease Control and Prevention, Janssen, Merck, Novartis, and Pfizer; has been a noncompensated investigator for Sanofi; and has a patent pending for Nix-Tix tick remover. Ms Bridgman, Dr Li, Dr Tabung, and Dr Cho have no conflicts of interest to disclose. |
|
| Reprints not available from the authors. |
Vol 80 - N° 6
P. 1682-1690 - juin 2019 Retour au numéro
Article précédent
- Patients believe that cosmetic procedures affect their quality of life: An interview study of patient-reported motivations
- Abigail Waldman, Amanda Maisel, Alexandra Weil, Sanjana Iyengar, Kaitlyn Sacotte, Jake M. Lazaroff, Sasha Kurumety, Sara L. Shaunfield, Kelly A. Reynolds, Emily Poon, June K. Robinson, Murad Alam
- Randomized phase 3 evaluation of trifarotene 50 ?g/g cream treatment of moderate facial and truncal acne
- Jerry Tan, Diane Thiboutot, Georg Popp, Melinda Gooderham, Charles Lynde, James Del Rosso, Jonathan Weiss, Ulrike Blume-Peytavi, Jolanta Weglovska, Sandra Johnson, Lawrence Parish, Dagmara Witkowska, Nestor Sanchez Colon, Alessandra Alió Saenz, Faiz Ahmad, Michael Graeber, Linda Stein Gold
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?